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Abstract
Introduction: Poor harmonization of critical results management is present in various laboratories and countries, including Croatia. We aimed to 
investigate procedures used in critical results reporting in Croatian medical biochemistry laboratories (MBLs).
Materials and methods: An anonymous questionnaire, consisting of 24 questions/statements, related to critical results reporting procedures, was 
send to managers of MBLs in Croatia. Participants were asked to declare the frequency of performing procedures and degree of agreement with sta-
tements about critical values reporting using a Likert scale. Total score and mean scores for corresponding separate statements divided according to 
health care setting were calculated and compared. 
Results: Responses from 111 Croatian laboratories (48%) were analyzed. General practice laboratories (GPLs) more often re-analyzed the sample 
before reporting the critical result in comparison with the hospital laboratories (HLs) (score: 4.86 (4.75-4.96) vs. 4.49 (4.25-4.72); P = 0.001) and 
more often reported the critical value exclusively to the responsible physician compared to HLs (4.46 (4.29-4.64) vs. 3.76 (3.48-4.03), P < 0.001). High 
total score (4.69 (4.56-4.82)) was observed for selection of the critical results list issued by the Croatian Chamber of Medical Biochemistry (CCMB) in-
dicating a high harmonization level for this aspect of critical result management. Low total scores were observed for the statements regarding data 
recording and documentation of critical result notification. 
Conclusions: Differences in practices about critical results reporting between HLs and GPLs were found. The homogeneity of least favorable res-
ponses detected for data recording and documentation of critical results notification reflects the lack of specific national recommendations. 
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In the last few decades, increasing evidence has 
emerged that the pre- and post-analytical phases 
of the total testing process are more prone to er-
rors than the highly automated analytical phase. 
Consequently, the focus of interest of the medical 
laboratory community shifted to reinforcing the 
quality of the post-analytical phase as a necessary 
step in error reduction and patient safety improve-
ment. A key post-analytical issue at the laboratory-
clinical interface is the effectiveness of laboratory 
data communication, i.e. critical test results report-
ing (1,2). 
A critical result is any result that is so extremely ab-
normal that can be considered life threatening or 
could result in significant morbidity and which, 
therefore, require urgent action, as originally de-
fined by Lundberg over 40 years ago (3,4). Timely 
release and reporting of critical results is essential 
for optimal clinical care. The importance of criti-
cal results reporting has been recognized by in-
ternational accreditation and regulatory bodies. 
The EN ISO 15189:2012 standard and accreditation 
standards in the UK, USA and Australia, require 
that laboratories establish documented proce-
dures for the immediate notification of results that 
fall within established “alert” or “critical” intervals 
to responsible clinical personnel (5,6). Further-
more, critical results reporting (i.e. notification of 
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critical values) was included in the consensus list 
of quality indicators of the International Federa-
tion of Clinical Chemistry and Laboratory Medi-
cine Working group on laboratory errors and pa-
tients safety’s (IFCC LEPS) as a process indicator of 
first priority for the evaluation and monitoring of 
post-analytical quality (7,8). 
Since accreditation standards give just general 
guidance and no specific or universally applicable 
procedure in managing critical results is proposed, 
practices related to critical results reporting are 
heterogeneous among laboratories and coun-
tries. Accordingly, several national professional or-
ganizations carried out surveys to investigate 
practices and policies of critical result manage-
ment in their countries in an attempt to formulate 
specific recommendations and finally harmonize 
critical result notification (9-13).
In 2006 the Croatian Chamber of Medical Bio-
chemists (CCMB) issued a supplement of good lab-
oratory practice standards currently used in the 
majority of laboratories in our country. This docu-
ment was entitled “Critical values”, and after a brief 
definition of the term, it stated that “laboratory 
should inform the physician about the critical re-
sult only after repeating the measurement and af-
ter result verification by a competent person who 
should discuss the obtained result with the physi-
cian”. Furthermore, a critical results list was com-
piled comprising threshold values for various ana-
lytes, both for adults and children (Table 1) (14). 
This CCMB document set the foundations for har-
monization of critical result reporting in Croatia. 
Nevertheless, we hypothesized that great variabil-
ity in policies and procedures for critical results re-
porting is present in medical biochemistry labora-
tories (MBLs) in Croatia. This variability particularly 
refers to: a) responsibilities (competences) for criti-
cal results communication (who notifies and to 
whom), b) channels for critical results communi-
cation, c) timeliness of critical values reporting 
and d) procedures for data recording regarding 
critical results notification, while a high level of 
harmonization is achieved in the selection of criti-
cal result limits. In addition, we hypothesize that 
hospitals laboratories, where critical results are ex-
pected in higher frequency, are more aware of the 
importance of critical results reporting and readily 
comply with appropriate procedures for this seg-
ment of the post-analytical phase. 
This survey aims to investigate policies and proce-
dures currently used in critical results reporting in 
MBLs in Croatia. We attempted to assess the varia-
tions in practices and identify critical aspects (i.e. 
less harmonized procedures) in existing critical re-
sults management systems. 
Materials and methods
Questionnaire
An anonymous questionnaire, consisting of 24 
questions / statements related to critical results re-
porting procedures and attitudes, was send to a 
total of 231 MBL manager in Croatia, identified us-
ing the Croatian Society of Medical Biochemistry 
and Laboratory Medicine (CSMBLM) database. The 
participants were surveyed using the online sur-
vey platform SurveyMonkey (SurveyMonkey Inc., 
Palo Alto, USA) during May 2014. Due to poor re-
sponse rate in the first round (only 18 MBLs re-
sponded), during June 2014, the authors contact-
ed each laboratory manager from the database by 
phone, briefly explaining the aim of the question-
naire and asking if they were willing to participate 
in the survey. Anonymity was ensured to those 
who accepted to participate. Those who declared 
to have participated in the first round were not 
surveyed in the second round.
The questionnaire was divided in three sections. 
The first section included questions on type of 
laboratory (i.e. health care setting), accreditation 
status, laboratory (LIS) and hospital information 
system (HIS) availability, reporting responsibilities 
and preferred communication channels. The sec-
ond section was designed as statements describ-
ing laboratory procedures regarding critical result 
management. The participants were asked to de-
clare the frequencies of procedures performed in 
their laboratories on a five grade Likert scale grad-
ed as 1 (never), 2 (rarely), 3 (sometimes), 4 (often) 
and 5 (always). The third section was designed as 
statements regarding reporting policies and 
choice of critical result limits. Responses were of-
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Parameter Value Note
Activated partial 
thromboplastin time (APTT) 75 sec Deficiency or inactivity of factor VIII, IX, or XII, with risk of haemorrhage.
AST, ALT > 1000 U/L Notification depends on the patient population of the clinic or practice in question.
Ammonia > 59 μmol/L Risk of hepatic encephalopathy. 
Anion gap > 20 mmol/L Indicative of ketoacidosis or lactacidosis, uraemia, alcohol consumption, salicylate intoxication, poisoning from methanol or ethylene glycol.
Inorganic
phosphate
< 0.32 mmol/L Muscle weakness, muscle pain, central-nervous symptoms such as disorientation, confusion, convulsions, coma, respiratory insufficiency with metabolic acidosis.
> 2.9 mmol/L Occurs in acute tumour lysis syndrome and in terminal renal failure.
Antithrombin (AT) < 0.50 There is substantial inhibitor deficiency, which in those with elevated procoagulant activity poses a high risk of thromboembolic complications.
Ethanol > 3.5 g/L Blood alcohol concentrations of 3-4 g/L can be fatal.




< 0.78 mmol/L Hypocalcaemic tetany
> 3.5 mmol/L
> 1.6 mmol/L
Risk of hypercalcaemic crisis, metabolic encephalopathy and gastrointestinal 
complications
Chloride
< 75 mmol/L Indicative of considerable metabolic alkalosis. 
> 125 mmol/L Indicative of massive primary metabolic acidosis or pseudohyperchloraemia in the case of bromide intoxication.
Creatinine > 654 μmol/L Acute renal failure, e.g. in multiple organ failure.
Creatine kinase > 1000 U/L Notification depends on the patient population of the clinic or practice in question.
D-dimers Positive
In disseminated intravascular coagulation (DIC), detection of D-dimers is 
indicative of phase II (decompensated activation of the haemostasis system) or 
phase III (full-blown DIC).
Digoxin > 2.0 μg/L (2.56 nmol/L) Non-cardiac symptoms such as tiredness, muscle weakness, nausea, vomiting, 
lethargy, and headache and cardiac symptoms such as sinus arrhythmia, 
bradycardia, and various degrees of AV block.Digitoxin > 40 μg/L (52 nmol/L)
Fibrinogen < 0.8 g/L Risk of haemorrhage.
Fibrin monomers Positive
Indicative of consumption coagulopathy in disseminated intravascular 
coagulation, sepsis, shock, multiple injury, acute pancreatitis, and obstetric 
complications.
Glucose
< 2.5 mmol/L Neuroglycopenic symptoms, which can range from impairment of cognitive functions to loss of consciousness. 
> 27.8 mmol/L
Diabetic coma due to insulin deficiency. Development of osmotic diuresis with 
severe exsiccosis and diabetic ketoacidosis (β-hydroxybutyrate > 5 mmol/L, 
standard
bicarbonate < 10 mmol/L).
Haematocrit 
< 0.180 L/L Corresponds to hemoglobin concentration of < 60 g/L. Inadequate myocardial oxygen supply.
> 0.610 L/L Blood hyperviscosity. Risk of heart failure.
Hemoglobin
< 66 g/L Supply of oxygen to the myocardium inadequate.
> 199 g/L Corresponds to haematocrit of 61 % and leads to hyperviscosity syndrome.
Table 1. Adults critical result list of the Croatian Chamber of Medical Biochemists.*
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Parameter Value Note
Lactate > 5.0 mmol/L Indicator of type A hyperlactataemia, which is caused by an inadequate supply of oxygen to the tissue. Pyruvate is no longer metabolised oxidatively, but reductively.
Lactate dehydrogenase > 500 U/L Notification depends on the patient population of the clinic or practice in question.
Leukocyte count
< 2 x109 /L High risk of infection if the granulocyte count is < 0.5 x109/L. 
> 50 x109 /L Indicative of leukemoid reaction, e.g. in sepsis, or of leukemia.
Lipase > 700 U/L Indicative of acute pancreatitis.
Magnesium
< 0.41 mmol/L
Characteristic symptoms are paresthesias, cramp, irritability, and athetoid tetany. 
The patient often shows cardiac arrhythmia in conjunction with hypokalemia; 
arrhythmia is intensified by digitalis. 
> 5.0 mmol/L
Reduction of neuromuscular impulse transmission, resulting in sedation, 
hypoventilation with respiratory acidosis, muscle weakness, and reduced tendon 
reflexes.
Myoglobin > 110 μg/L Myocardial infarction should be suspected in patients with angina pectoris.
Sodium
< 120 mmol/L Tonicity disturbances caused by disorder of the mechanism ADH-thirst, water absorption or the ability of the kidney to concentrate or dilute the urine.








Cellular water loss and intracellular increase in osmotically active substances, 
which do not permeate the cell membrane. Result: central symptoms and coma.
Osmolar gap > 10 mOsm/kg H2O
Indicative of intoxication from non-electrolytes, which increase plasma 







pH < 7.2> 7.6
Such pH values are characteristic of severely decompensated acidosis or alkalosis. 
Values < 7.20 and > 7.60 are life-threatening
pO2 < 5.7 kPa
Such values correspond to a haemoglobin oxygen saturation of less than 80 % 
and are to be regarded as life-threatening.
Potassium
< 2.8 mmol/L Neuromuscular symptoms; weakness of skeletal muscles; paralysis; cardiac arrest. Changes in ECG





Indicative of thyrotoxicosis. Possible causes: Graves’ disease, trophoblastic 
tumour, hyperfunctional adenoma, toxic nodular goitre, and, in rare instances, 
overproduction of TSH.
Prothrombin time (PT) > 40 sec (< 0.15)
Decrease in the vitamin K-dependent factors II, VII, and X or in factor V. 
Disturbances in liver synthesis. In persons receiving coumarin therapy, there is a 
risk of haemorrhage if the PT is < 0.15 – which corresponds roughly to an INR of > 4.
Platelet count
< 20 x109 /L Risk of haemorrhage. Exclude EDTA-induced thrombocytopenia.
> 1000 x109 /L Risk of thrombosis.
Troponin > 0.1 μg/L Indicative of myocardial infarct or unstable angina pectoris.
Uric acid > 773 mmol/L Acute urate nephropathy with tubular blockade and renal failure. 
Urea > 35.6 mmol/L Indicative of acute renal failure; unlike pre-renal and post-renal kidney failure, no disproportionate increase in urea compared to creatinine in serum.
*Available at: http://www.hkmb.hr/povjerenstva/strucna-pitanja.html#1 (14).
Table 1. Continued.
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fered as degree of agreement with proposed 
statements on a five grade Likert scale graded as 1 
(completely disagree), 2 (mostly disagree), 3 (nei-
ther agree nor disagree), 4 (mostly agree) and 5 
(completely agree). Thus, MBLs with the most fa-
vorable responses had the highest score, while 
MBLs with the least favorable responses had the 
lowest score. 
Statistical analysis
The questionnaire’s internal consistency was de-
termined by calculating Cronbach’s alpha coeffi-
cient (α). Value of alpha > 0.70 indicates good sur-
vey reliability (15). Demographic characteristics of 
surveyed laboratories were presented as numbers 
and percentages (for questions on type of labora-
tory and critical results reporting policies). Re-
sponses to individual statements were presented 
as mean score with corresponding 95% confi-
dence interval (CI). The mean score was calculated 
from scores for corresponding separate state-
ments divided according to health care setting. 
Total score with 95% CI for all statements was cal-
culated as the mean of all individual responses’ 
score. Since parametric methods are robust 
enough and can be used on ordinal data, we used 
a parametric statistical approach for data analysis 
(16). Differences in obtained scores between two 
groups were calculated using the Mann-Whitney 
test for independent samples. P < 0.05 was consid-
ered statistically significant. All statistical analyses 
were performed using MedCalc statistical soft-
ware version 11.5.1 (MedCalc, Mariakerke, Bel-
gium). 
Results
Cronbach’s alpha coefficient for our survey was α 
= 0.79, indicating a good reliability of the obtained 
test scores. A total of 111 laboratories participated 
in this survey, which represents 48% of MBLs. The 
total score of 3.64 (3.57–3.72) (on a scale from 1 to 
5) for all statements surveyed was obtained.
The characteristics of the participating laborato-
ries and general critical results policies are pre-
sented in Table 2. Hospital laboratories (HLs) com-
Parameter N %
Laboratories by health care setting
Hospital laboratories 41 36.9
General practice laboratories 70 63.1
Accreditation status
Accredited 5 4.5
Accreditation in process 1 0.9











MSc and specialists 42 38.2
All laboratory personnel (technical 




Fax, e-mail, other 6 5.5
All of the above 4 3.6
Timeframe of critical results reporting
Up to 15 minutes 63 57.3
Up to 30 minutes 28 25.5
Up to 1 hour 15 13.6
More than 1 hour 4 3.6
LIS – laboratory information system; HIS – hospital information 
system; MSc – master of medical biochemistry; Specialists – 
specialists in laboratory medicine.
Table 2. Characteristics and general critical results reporting 
policies of surveyed laboratories in Croatia.
prised laboratories located in special hospitals, 
general hospitals, clinics, clinical hospitals and 
clinical hospital centers, while primary care, pri-
vate laboratories and polyclinic laboratories were 
designated as general practice laboratories (GPLs). 
The majority of laboratories who responded to the 
survey were GPLs compared to HLs (63.1% vs. 
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36.9%, respectively, analysis not shown) and non-
accredited laboratories (94.5%, analysis not 
shown). Of all laboratories who participated, only 
one declared not to report critical results, leaving 
110 laboratories for further analysis. In the majority 
of surveyed laboratories (61.8%, P = 0.017; analysis 
not shown) critical result reporting is the responsi-
bility of all laboratory staff (i.e. managing person-
nel - master of medical biochemistry and special-
ists in laboratory medicine, and non-managing 
personnel – bachelor of science in laboratory diag-
nostics and medical laboratory technicians). The 
preferred channel for communicating critical re-
sults is by phone (90.9%, P < 0.001; analysis not 
shown). The majority of participants reported to 
notify critical results in a time frame of up to 15 
minutes after re-testing and verification (57.3%, P 
< 0.001; analysis not shown).
Mean scores for statements regarding critical re-
sults reporting procedures of surveyed Croatian 
laboratories are presented in Table 3. When re-
porting critical test results, laboratories most often 











vs . general 
practice)
When reporting critical test results, the laboratory staff 
uses the values issued by the CCMB. 4.69 (4.56-4.82) 4.56 (4.29-4.83) 4.77 (4.63-4.91) 0.296
Before reporting critical test result, the analysis is repeated. 4.72 (4.61-4.83) 4.49 (4.25-4.72) 4.86 (4.75-4.96) 0 .001*
The critical test result is notified exclusively to the 
responsible physician. 4.20 (4.04-4.36) 3.76 (3.48-4.03) 4.46 (4.29-4.64) < 0 .001*
When reporting the critical test result, it customary to briefly 
comment the obtained results with the recipient of the 
results, in order to eliminate possible preanalytical errors.
4.15 (3.98-4.33) 4.15 (3.88-4.42) 4.16 (3.93-4.39) 0.727
When reporting the critical test result, it is customary 
to ask the recipient of the result to read-back the value 
notified.
3.16 (2.86-3.46) 3.41 (2.96-3.87) 3.01 (2.62-3.41) 0.258
Reporting of critical test results is systematically recorded. 3.86 (3.56-4.17) 3.98 (3.47-4.48) 3.80 (3.40-4.19) 0.555
The identity of the individual who reported the critical test 
result is collected within the record. 3.43 (3.07-3.79) 3.88 (3.34-4.42) 3.16 (2.70-3.62) 0 .045*
The identity of the recipient of the critical test result is 
collected within the record. 3.74 (3.40-4.07) 3.98 (3.47-4.48) 3.59 (3.15-4.03) 0.380
The record contains the patient’s unique identification 
number. 2.65 (2.31-3.00) 2.88 (2.29-3.47) 2.52 (2.09-2.96) 0.312
The record contains the test value with the unit of measure 
of the critical test result reported. 3.74 (3.39-4.08) 3.78 (3.22-4.34) 3.71 (3.27-4.15) 0.991
The recorded data pertaining critical test results reporting 
are easily accessible for periodical evaluation? 2.95 (2.60-3.31) 3.29 (2.73-3.86) 2.75 (2.30-3.21) 0.144
Contact information for critical results reporting (phone 
number / fax / e-mail) are available on the test request. 2.06 (1.78-2.34) 2.32 (1.85-2.79) 1.91 (1.56-2.27) 0.068
The reporting of critical result is recorded on test report 
(i.e. as a comment). 2.00 (1.70-2.30) 2.37 (1.83-2.90) 1.78 (1.43-2.14) 0 .033*
CCMB – Croatian Chamber of Medical Biochemists. Total score and mean scores for hospital and general practice laboratories are 
presented as mean (95% CI). 95% CI – 95% confidence interval. *Difference between hospital and general practice laboratories 
mean scores were calculated the Mann-Whitney test for independent samples. P<0.05 was considered statistically significant. 
*Statistically significant difference.
Table 3. Comparison of mean scores for critical results reporting procedures of surveyed Croatian laboratories.
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used the critical result list issued by CCMB (score 
(95% CI) = 4.69 (4.56-4.82)). According to the ob-
tained high score, Croatian laboratories in general 
re-analyze critical results before reporting (4.72 
(4.61-4.83)). GPLs more often re-analyzed the sam-
ple before reporting the critical result in compari-
son with HLs (score: 4.86 (4.75-4.96) vs. 4.49 (4.25-
4.72); P = 0.001). GPLs more often reported the crit-
ical result exclusively to the responsible physician 
(4.46 (4.29-4.64) vs. 3.76 (3.48-4.03), P < 0.001). Low 
mean scores were obtained for statements regard-
ing the recording of critical result notification. HLs 
more often recorded details about the identity of 
who reported the critical test result (3.88 (3.34-
4.42) vs. 3.16 (2.70-3.62), P = 0.045, respectively) 
and more often recorded the critical result notifi-
cation on the test report (2.37 (1.83-2.90) vs. 1.78 
(1.43-2.14), P = 0.033, respectively). 
Table 4 presents mean scores collected from sur-
veyed laboratories for attitudes towards critical re-
sults reporting. All the MBLs surveyed acknowl-
edge that timely reporting of critical results influ-
ences the patient outcome (4.76 (4.66-4.87)). The 
agreement with the statement that CCMB list of 
critical results is complete and does not need revi-
sion differed significantly between GPL and HL: 
the list was more satisfactory for the GPLs, than for 
HLs (score: 4.58 (4.43-4.72) vs. 4.10 (3.86-4.34); P < 
0.001).
Discussion
In this investigation, we surveyed policies and pro-
cedures currently used in critical results reporting 
in Croatia. The total score of 3.64 (on a scale from 1 
to 5) for all statements surveyed can be regarded 
as an indicator of very good practice in critical re-
sults reporting in Croatia. However, considerable 
deviations from desirable procedures for critical 
result reporting were demonstrated for state-
ments regarding recording and documentation of 
critical results notification. The homogeneity of 
least favorable responses (evidenced by lower 
scores) detected for this segment of critical result 
reporting procedures reflects the lack of specific 
and definite recommendations (local and / or na-
tional). 
Although critical results comprise just up to 2% of 
all laboratory results, it is the MBL’s responsibility 
to monitor this important part of the post-analyti-
cal phase (11,17). Accreditation and patient safety 
standards require MBLs to have a management 
system for timely and reliable critical results notifi-
cation. Key procedures in a critical results manage-
ment system that require harmonization are: a) 
definition of the term “critical result”, b) compila-
tion of a critical limits list, c) definition of critical re-
sult reporting procedures, with special emphasis 
on timeliness of reporting, and communicating 
procedures as to who reports, to whom the critical 
result is reported and how is receipt of the result 













Timely reporting of critical results influences the patient 
outcome. 4.76 (4.66-4.87) 4.71 (4.55-4.87) 4.80 (4.65-4.94) 0.136
The recommended critical value list issued by the CCMB 
comprises all the analytes needed in your routine work. 4.40 (4.27-4.53) 4.10 (3.86-4.34) 4.58 (4.43-4.72) < 0 .001*
The recommended critical value list issued by the CCMB 
does not need a revision. 3.79 (3.59-4.00) 3.41 (3.03-3.80) 4.01 (3.79-4.24) 0 .012*
CCMB – Croatian Chamber of Medical Biochemists; Total score and mean scores for hospital and general practice laboratories are 
presented as mean (95% CI); 95% CI – 95% confidence interval. Difference between hospital and general practice laboratories 
mean scores were calculated the Mann-Whitney test for independent samples. P < 0.05 was considered statistically significant. 
*Statistically significant difference.
Table 4. Comparison of scores for attitudes towards critical results reporting
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confirmed, d) definition of data that should be re-
corded, e) establishment of procedures for moni-
toring and evaluating the performance of critical 
results management procedures (5,18). This survey 
was designed to identify variations in these proce-
dures on a national level. 
We demonstrated that all MBLs (i.e. HLs and GPLs) 
in Croatia are almost equally aware of the impor-
tance of reporting critical results. All the MBLs sur-
veyed (with one exception) declared the imple-
mentation of this valuable post-analytical quality 
indicator into routine practice. As expected, high 
level of harmonization is achieved nationally re-
garding the selection of critical result limits. The 
favorable total score of 4.69 can be explained by 
high adherence to the critical results list provided 
by CCMB. The values provided in the CCMB list are 
literature derived (19) and MBLs in Croatia mostly 
agree that it comprises all the analytes necessary 
for their routine work. Hospital laboratories, how-
ever, opine that the CCMB list of critical results 
needs reviewing and up-dating. The CCMB list of 
critical values has contributed greatly to the har-
monization of this aspect of critical result manage-
ment, but it must be emphasized that critical re-
sult lists should be tailored by each individual lab-
oratory, in consultation with physicians/clinicians, 
thus implementing data from published literature 
with professional experience (5,17,20). Expectedly, 
this aspect of critical results management will 
hardly ever achieve complete national harmoniza-
tion.
Since national recommendations for critical results 
reporting procedures are not available in Croatia, 
differences in critical results reporting between 
MBLs surveyed were detected. Our results suggest 
that critical result reporting is considered a re-
sponsibility of all laboratory personnel since the 
majority of MBLs investigated declared that tech-
nical as well as managing staff are involved in criti-
cal results communication. This is in contrast with 
findings from previously published surveys. Re-
sults from the majority of similar national surveys 
indicate that laboratory technicians, who per-
formed the test, were responsible for critical result 
reporting (10-13,21). However, in Italy laboratory 
managers are predominantly involved in critical 
test result communication (9,22). 
A 90.9% of MBLs surveyed in Croatia stated to use 
the phone as the preferred mechanism for critical 
result reporting. These results are in accordance 
with all previously published data (11-13,21,22). 
However, increasing interest has been demon-
strated for alternative channels of communication, 
based on automation and/or information technol-
ogy, that are faster and closer to the physician and 
the patient (13,23-25). 
The EN ISO 15189:2012 standard for medical labo-
ratories considers “physicians or other authorized 
health professionals” suitable recipients of critical 
results (6). The CCMB document specifies that the 
physician is the acceptable recipient of critical re-
sults (14). Our survey revealed that general prac-
tice laboratories in Croatia achieved a higher score, 
compared to hospital laboratories, regarding noti-
fication of critical results exclusively to responsible 
physicians. This result is very interesting since it 
has been demonstrated that contacting a physi-
cian, especially in an outpatient setting and/or af-
ter office hours, is considered the greatest obsta-
cle to timely critical result reporting (9,11,13,17). It 
can be concluded that general practice laborato-
ries in Croatia seem more determined and prone 
to comply with local regulations compared to hos-
pital MBLs, although we acknowledge that hospi-
tal physicians cannot always be reached by phone 
because of the tasks’ complexity in hospital care. 
Re-analyzing of critical results before their notifi-
cation is standard practice in Croatia (total score 
4.72). Hospital laboratories achieved a lower score 
for re-analyzing before reporting critical result, 
which suggests lesser frequency of re-analyzing in 
this clinical setting. Indeed, although the CCMB 
recommends re-analyzing critical tests to rule out 
possible erroneous results, recent investigations 
demonstrated that re-analyzing of critical results 
adds little to test reliability, and ultimately to pa-
tient safety (17). Additionally, repeated verifica-
tions necessarily delay critical results notification 
and increase laboratory costs (26-28).
Timeliness is a crucial aspect of critical result re-
porting. No recommendations are available, but a 
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mean “in laboratory” turnaround time (TAT) for 
critical values of 22 minutes was obtained for a 
large academic medical centre. Thus the authors 
set the limit of acceptability of TAT for critical val-
ues at 30 minutes (23). In another investigation, 
notification median time from result verification 
was found to be 4 minutes and median time from 
collection to first result was 48 minutes. The au-
thors emphasized the need to establish laboratory 
timeframes for critical value reporting and pro-
posed that 15-30 minutes after test completion 
seems a reasonable goal (10). According to our re-
sults, 82.8% of surveyed MBLs in Croatia meet this 
proposed goal (i.e. they notify critical results in a 
timeframe up to 30 minutes from result verifica-
tion). 
The communication of critical test results directly 
affects patient outcome, thus erroneous notifica-
tion of critical test results can be considered a 
medical error. Read-back of verbally reported criti-
cal values is an established way of acknowledging 
result receipt, although variable practices are pre-
sent across countries (17,22,29). The obtained score 
for read-back procedures of critical results in Croa-
tia indicates that this aspect of critical result man-
agement could be improved. Efforts should in-
clude education of laboratory but also medical 
staff to raise the awareness of importance of read-
back procedures for improving patient safety. 
According to the EN ISO 15189:2012 standard, the 
laboratory should keep records of “actions taken 
that document date, time, responsible laboratory 
staff member, person notified and examination re-
sults conveyed, and any difficulties encountered in 
notifications” (6). This data recording enables labo-
ratories to monitor and measure their perfor-
mance in notifying critical results and identify pos-
sible improvements (17). Our results indicate that 
low mean scores, with practically no differences 
among hospital and general practice laboratories 
in Croatia, were observed for statements regard-
ing recording of data and performance evaluation 
of critical result notification. It must be noted that 
hospital laboratories obtained slightly better 
scores for recording the identity of who reported 
the critical test result and recording the critical re-
sult notification on the test report. This extremely 
important aspect of critical result management 
calls for urgent improvement in Croatian laborato-
ries. 
We have to acknowledge a few limitations of our 
study. Firstly, the response rate of our nationwide 
survey was 48%, which means that our results may 
not be representative of all Croatian MBLs. Fur-
thermore, data from our participants were self-re-
ported and thus could not be independently veri-
fied. 
In conclusion, our results confirm that considera-
ble deviations from desirable procedures for criti-
cal result management are present in Croatia. 
Thus, the urgent need of nationally and/or locally 
established policies and procedures for the man-
agement of critical results is evident. Variations in 
practices reported after surveys on critical result 
reporting procedures have been observed to trig-
ger the formulation of recommendations on criti-
cal results reporting (17,30,31). Therefore, we be-
lieve that this investigation will contribute to the 
achievement of this desirable scenario in Croatia 
as well.
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